BRAF and dysplastic nevus: As seen in melanoma, the inhibition of the Raf stimulating effect of PTPIP51 can be used as a counter-regulatory mechanism against the BRAF deregulation within the sequence from normal nevi over dysplastic nevi to melanoma.